Bei Tan

2.5k total citations · 1 hit paper
86 papers, 1.9k citations indexed

About

Bei Tan is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Bei Tan has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Epidemiology and 24 papers in Surgery. Recurrent topics in Bei Tan's work include Gut microbiota and health (21 papers), Inflammatory Bowel Disease (18 papers) and Microscopic Colitis (14 papers). Bei Tan is often cited by papers focused on Gut microbiota and health (21 papers), Inflammatory Bowel Disease (18 papers) and Microscopic Colitis (14 papers). Bei Tan collaborates with scholars based in China, United States and Rwanda. Bei Tan's co-authors include Zhaohua Shen, Xiaoyan Wang, Weiwei Luo, Shuai Wu, Yongsheng Quan, Zhenyu Yang, Changxin Zhu, Zhong Chen, Yi Wang and Mengwei Xiao and has published in prestigious journals such as Gastroenterology, PLoS ONE and Annals of Neurology.

In The Last Decade

Bei Tan

77 papers receiving 1.9k citations

Hit Papers

Relationship between intestinal microbiota and ulcerative... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bei Tan China 21 1.0k 456 317 264 259 86 1.9k
Yuqiang Nie China 26 1.3k 1.3× 347 0.8× 352 1.1× 286 1.1× 401 1.5× 69 2.2k
Le Liu China 18 883 0.9× 288 0.6× 211 0.7× 253 1.0× 197 0.8× 52 1.6k
Christel Rousseaux France 14 662 0.7× 456 1.0× 298 0.9× 331 1.3× 134 0.5× 31 1.6k
Arivarasu Natarajan Anbazhagan United States 24 840 0.8× 236 0.5× 154 0.5× 347 1.3× 139 0.5× 71 1.9k
Jean‐Pierre Segain France 18 1.2k 1.2× 476 1.0× 254 0.8× 362 1.4× 200 0.8× 27 2.3k
Eunha Kim South Korea 18 1.0k 1.0× 247 0.5× 356 1.1× 241 0.9× 175 0.7× 37 2.0k
Mark E. Gerich United States 18 945 0.9× 383 0.8× 220 0.7× 211 0.8× 146 0.6× 38 1.8k
Gurminder Singh United States 15 799 0.8× 257 0.6× 289 0.9× 255 1.0× 101 0.4× 27 1.7k
Natividad Garrido‐Mesa Spain 24 711 0.7× 248 0.5× 154 0.5× 159 0.6× 124 0.5× 35 2.1k
Jay R. Thiagarajah United States 32 1.9k 1.8× 336 0.7× 206 0.6× 465 1.8× 207 0.8× 64 3.8k

Countries citing papers authored by Bei Tan

Since Specialization
Citations

This map shows the geographic impact of Bei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Tan more than expected).

Fields of papers citing papers by Bei Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Tan. The network helps show where Bei Tan may publish in the future.

Co-authorship network of co-authors of Bei Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Tan. A scholar is included among the top collaborators of Bei Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Tan. Bei Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Muhan, Bei Tan, Shengyu Zhang, et al.. (2025). Comprehensive insights into pathogenesis, diagnosis, treatment, and prognosis in adult autoimmune enteropathy. Orphanet Journal of Rare Diseases. 20(1). 208–208. 1 indexed citations
3.
Chen, Jie, Pei Zhang, Siyuan Qin, et al.. (2023). Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome. Analytica Chimica Acta. 1241. 340807–340807. 10 indexed citations
4.
Yu, Si, Xiaomeng Ge, Hui Xu, et al.. (2023). Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection. Frontiers in Cellular and Infection Microbiology. 13. 1129043–1129043. 15 indexed citations
5.
Wang, Yu, Jiaying Liu, Bei Tan, et al.. (2023). (+)-Borneol enantiomer ameliorates epileptic seizure via decreasing the excitability of glutamatergic transmission. Acta Pharmacologica Sinica. 44(8). 1600–1611. 10 indexed citations
6.
Zhang, Qi, Xiaojie Chen, Fan Fei, et al.. (2023). Electro-responsive micelle-based universal drug delivery system for on-demand therapy in epilepsy. Journal of Controlled Release. 360. 759–771. 15 indexed citations
7.
Liu, Xinyu, Hao Tang, Bo Lü, et al.. (2023). Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events. Frontiers in Oncology. 13. 1144534–1144534. 10 indexed citations
8.
Liu, Rongbei, Jing Hu, Jian Tang, et al.. (2023). Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study. Inflammatory Bowel Diseases. 30(1). 45–52. 6 indexed citations
9.
Tan, Bei, Yu Du, Lin Yang, et al.. (2023). Glutamatergic and GABAergic neurons in the vLGN mediate the nociceptive effects of green and red light on neuropathic pain. Neurobiology of Disease. 183. 106164–106164. 7 indexed citations
10.
Shen, Zhaohua, Weiwei Luo, Bei Tan, et al.. (2022). Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease. EBioMedicine. 85. 104285–104285. 59 indexed citations
11.
Luo, Weiwei, Li Tian, Bei Tan, et al.. (2021). Update: Innate Lymphoid Cells in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 67(1). 56–66. 41 indexed citations
12.
Wu, Xing, Weiwei Luo, Zhaohua Shen, et al.. (2020). Roseburia�intestinalis‑derived flagellin ameliorates colitis by targeting miR‑223‑3p‑mediated activation of NLRP3 inflammasome and pyroptosis. Molecular Medicine Reports. 22(4). 2695–2704. 69 indexed citations
14.
Quan, Yongsheng, Yan Zhang, Changxin Zhu, et al.. (2018). Roseburia intestinalis -derived flagellin is a negative regulator of intestinal inflammation. Biochemical and Biophysical Research Communications. 501(3). 791–799. 59 indexed citations
15.
Zhu, Changxin, Zhaohua Shen, Yongsheng Quan, et al.. (2018). Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis. Molecular Medicine Reports. 17(6). 7567–7574. 118 indexed citations
16.
Li, Ji, Dong Wu, Hong Yang, et al.. (2017). Clinical characteristics of ulcerative colitis‐related colorectal cancer in Chinese patients. Journal of Digestive Diseases. 18(12). 684–690. 18 indexed citations
17.
Tan, Bei, Jyh‐Chin Yang, Carol Young, et al.. (2017). Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience. Digestive Diseases and Sciences. 63(2). 437–445. 20 indexed citations
18.
Tan, Bei, et al.. (2017). A Meta-analysis of Effectiveness Evaluation between Shexiang Baoxin Pill and Isosorbide Mononitrate Tablet. Journal of Pharmaceutical and Biomedical Sciences. 7(5). 1 indexed citations
19.
Li, Yue, et al.. (2016). Efficacy and safety of thalidomide in the treatment of 29 refractory Crohn's disease patients. Zhonghua xiaohua zazhi. 36(3). 172–176.
20.
Tan, Bei, et al.. (2014). Physicochemical properties and composition of snakehead fish (Channa striatus) whole fillet powder prepared with pre-filleting freezing treatments.. International Food Research Journal. 21(3). 1219–1224. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026